International Journal of Applied Research
Vol. 1, Issue 12, Part F (2015)
Anemia in Chronic Kidney Disease (Ckd) Patients
Background: In patients with chronic kidney disease, norm chromic normocytic anaemia mainly develops from decreased renal synthesis of erythropoietin. The anaemia becomes more severe as the Glomerular filtration rate (GFR) progressively decreases. No reticulocyte response occurs, red blood cell survival is decreased and there is an associated increased bleeding tendency due to uraemia-induced platelet dysfunction. Untreated anaemia of CKD is strongly associated with cardiovascular and renal complications, resulting in increased hospitalisations and mortality. Therefore, correcting anaemia is considered an important part of slowing or even stopping the progression of CKD.  rnMethods: In the present study, 50 patients of CKD admitted at GG Hospital, a tertiary care hospital, Jamnagar during period of 1 year, were included.rnResults: In the present study, 58% patients have moderate, 22% have mild and 20% have severe form of anaemia rnConclusion: As anaemia is common in developing country and CKD is affecting haemopoietic system, 78% patient of study having anaemia.
How to cite this article:
Mehul Kaliya, Mittal rathod, Aniruddha Gohel, Ajay Tanna, Manish Mehta. Anemia in Chronic Kidney Disease (Ckd) Patients. Int J Appl Res 2015;1(12):386-389.